부산대학교 도서관

Yates, Lucy R; Gerstung, Moritz; Knappskog, Stian; Desmedt, Christine; Gundem, Gunes; Van Loo, Peter; Aas, Turid; Alexandrov, Ludmil B; Larsimont, Denis; Davies, Helen; Li, Yilong; Ju, Young Seok; Ramakrishna, Manasa; Haugland, Hans Kristian; Lilleng, Peer Kaare; Nik-Zainal, Serena; McLaren, Stuart; Butler, Adam; Martin, Sancha; Glodzik, Dominic

Nature Medicine. Jul2015, Vol. 21 Issue 7, p751-759. 9p. 1 Color Photograph, 2 Diagrams, 3 Graphs.

Aftimos, Philippe; Oliveira, Mafalda; Irrthum, Alexandre; Fumagalli, Debora; Sotiriou, Christos; Gal-Yam, Einav Nili; Robson, Mark E; Ndozeng, Justin; Di Leo, Angelo; Ciruelos, Eva M; de Azambuja, Evandro; Viale, Giuseppe; Scheepers, Elsemieke D; Curigliano, Giuseppe; Bliss, Judith M; Reis-Filho, Jorge S; Colleoni, Marco; Balic, Marija; Cardoso, Fatima; Albanell, Joan; Duhem, Caroline; Marreaud, Sandrine; Romagnoli, Dario; Rojas, Beatriz; Gombos, Andrea; Wildiers, Hans; Guerrero-Zotano, Angel; Hall, Peter; Bonetti, Andrea; Larsson, Karolina Fs; Degiorgis, Martina; Khodaverdi, Silvia; Greil, Richard; Sverrisdóttir, Ásgerdur; Paoli, Marta; Seyll, Ethel; Loibl, Sibylle; Linderholm, Barbro; Zoppoli, Gabriele; Davidson, Nancy E; Johannsson, Oskar Th; Bedard, Philippe L; Loi, Sherene; Knox, Susan; Cameron, David A; Harbeck, Nadia; Montoya, Maite Lasa; Brandão, Mariana; Vingiani, Andrea; Caballero, Carmela; Hilbers, Florentine S; Yates, Lucy R; Benelli, Matteo; Venet, David; Piccart, Martine J

Cancer discovery. 11(11):2796-2811

Nathanson SD; Department of Surgery, Henry Ford Cancer Institute, 2799 W Grand Boulevard, Detroit, MI, USA. dnathan1@hfhs.org.; Detmar M; Institute of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland.; Padera TP; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Yates LR; Wellcome Sanger Institute, Cambridge, UK.; Welch DR; Department of Cancer Biology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS, USA.; Beadnell TC; Department of Cancer Biology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS, USA.; Scheid AD; Department of Cancer Biology, University of Kansas Medical Center and University of Kansas Cancer Center, Kansas City, KS, USA.; Wrenn ED; Translational Research Program, Public Health Sciences and Human Biology Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA.; Cheung K; Translational Research Program, Public Health Sciences and Human Biology Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8409970 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7276 (Electronic) Linking ISSN: 02620898 NLM ISO Abbreviation: Clin Exp Metastasis Subsets: MEDLINE

Seferbekova Z; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Lomakin A; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Yates LR; Wellcome Sanger Institute, Hinxton, UK.; Gerstung M; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany. moritz.gerstung@dkfz.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100962779 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-0064 (Electronic) Linking ISSN: 14710056 NLM ISO Abbreviation: Nat Rev Genet Subsets: MEDLINE

Lomakin A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Wellcome Sanger Institute, Hinxton, UK.; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Svedlund J; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.; Strell C; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.; Gataric M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Wellcome Sanger Institute, Hinxton, UK.; Shmatko A; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Rukhovich G; Wellcome Sanger Institute, Hinxton, UK.; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Park JS; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Wellcome Sanger Institute, Hinxton, UK.; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Ju YS; Laboratory of Cancer Genomics, GSMSE, KAIST, Daejeon, Korea.; Dentro S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Wellcome Sanger Institute, Hinxton, UK.; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany.; Kleshchevnikov V; Wellcome Sanger Institute, Hinxton, UK.; Vaskivskyi V; Wellcome Sanger Institute, Hinxton, UK.; Li T; Wellcome Sanger Institute, Hinxton, UK.; Bayraktar OA; Wellcome Sanger Institute, Hinxton, UK.; Pinder S; Guys and St Thomas' NHS Trust, London, UK.; School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.; Richardson AL; Department of Pathology, John Hopkins Medicine, Baltimore, MD, USA.; Santagata S; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Boston, MA, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, USA.; Campbell PJ; Wellcome Sanger Institute, Hinxton, UK.; Russnes H; Department of Pathology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Gerstung M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK. moritz.gerstung@dkfz.de.; Division of AI in Oncology, German Cancer Research Centre DKFZ, Heidelberg, Germany. moritz.gerstung@dkfz.de.; Nilsson M; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden. mats.nilsson@scilifelab.se.; Yates LR; Wellcome Sanger Institute, Hinxton, UK. ly2@sanger.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Anderson AC; Yanai I; Yates LR; Wang L; Swarbrick A; Sorger P; Santagata S; Fridman WH; Gao Q; Jerby L; Izar B; Shang L; Zhou X

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Petkovic M; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.; Elizalde S; Department of Mathematics, Dartmouth College, Hanover, NH, USA.; Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Bioinformatics Research Centre (BiRC), Aarhus University, Aarhus, Denmark.; Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.; Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Dewhurst SM; Laboratory for Cell Biology and Genetics, Rockefeller University, New York, NY, USA.; Demeulemeester J; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Department of Human Genetics, University of Leuven, Leuven, Belgium.; Dentro SC; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Oxford Big Data Institute, University of Oxford, Oxford, UK.; Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, UK.; Horswell S; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.; Au L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Haase K; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Escudero M; Department of Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.; Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.; Bakir MA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Xu H; Stanford Cancer Institute, Stanford, CA, USA.; Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Mourikis TP; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK.; Dietzen M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK.; Spain L; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Cresswell GD; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; Biswas D; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.; Lamy P; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Nordentoft I; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Harbst K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden.; Castro-Giner F; Department of Biomedicine, Cancer Metastasis Laboratory, University of Basel and University Hospital Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.; Yates LR; Wellcome Trust Sanger Institute, Hinxton, UK.; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; Caramia F; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Jaulin F; INSERM U1279, Gustave Roussy, Villejuif, France.; Vicier C; Department of Medical Oncology, Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.; Tomlinson IPM; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, UK.; Brastianos PK; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.; Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Cho RJ; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.; Bastian BC; Department of Dermatology, University of California, San Francisco, San Francisco, CA, USA.; Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA.; Dyrskjøt L; Department of Molecular Medicine (MOMA), Aarhus University Hospital, Aarhus, Denmark.; Jönsson GB; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Lund University Cancer Centre, Lund University, Lund, Sweden.; Savas P; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Loi S; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, UK.; Andre F; INSERM U981, PRISM Institute, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Medical School, Université Paris Saclay, Kremlin Bicetre, France.; Luscombe NM; Bioinformatics and Computational Biology Laboratory, The Francis Crick Institute, London, UK.; UCL Genetics Institute, Department of Genetics, Evolution & Environment, University College London, London, UK.; Okinawa Institute of Science & Technology, Okinawa, Japan.; Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Tjan-Heijnen VCG; Department of Medical Oncology, School of GROW, Maastricht University Medical Center, Maastricht, The Netherlands.; Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark.; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; 2nd Department of Pathology, SE-NAP Brain Metastasis Research Group, Semmelweis University, Budapest, Hungary.; Turajlic S; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.; Van Loo P; Cancer Genomics Laboratory, The Francis Crick Institute, London, UK.; Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Schwarz RF; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Consortium (DKTK), partner site Berlin, Berlin, Germany. roland.schwarz@mdc-berlin.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. roland.schwarz@mdc-berlin.de.; McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK. nicholas.mcgranahan.10@ucl.ac.uk.; Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. charles.swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. charles.swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, London, UK. charles.swanton@crick.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Fu Y; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Jung AW; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Torne RV; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Department of Computer Science and Technology, University of Cambridge, Cambridge, UK.; Gonzalez S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain.; Vöhringer H; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Shmatko A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Moscow State University, Moscow, Russia.; Yates LR; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.; Jimenez-Linan M; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.; Moore L; Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Hinxton, UK.; Department of Pathology, Addenbrooke's Hospital, Cambridge, UK.; Gerstung M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK. moritz.gerstung@ebi.ac.uk.; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany. moritz.gerstung@ebi.ac.uk.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Tubio JMC; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Li Y; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Ju YS; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Martincorena I; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Cooke SL; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Tojo M; Department of Physiology, School of Medicine-Center for Resesarch in Molecular Medicine and Chronic Diseases, Instituto de Investigaciones Sanitarias, University of Santiago de Compostela, Spain.; Gundem G; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Pipinikas CP; Lungs for Living Research Centre, Rayne Institute, University College London (UCL), London, UK.; Zamora J; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Raine K; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Menzies A; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Roman-Garcia P; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Fullam A; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Gerstung M; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Shlien A; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Tarpey PS; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Papaemmanuil E; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Knappskog S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Van Loo P; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Human Genome Laboratory, Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium.; Ramakrishna M; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Davies HR; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Marshall J; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Wedge DC; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Teague JW; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Butler AP; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK.; Alexandrov L; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Behjati S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Yates LR; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Bolli N; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Mudie L; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Hardy C; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Martin S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; McLaren S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; O'Meara S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Anderson E; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Maddison M; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Gamble S; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Foster C; University of Liverpool and HCA Pathology Laboratories, London, UK.; Warren AY; Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK.; Whitaker H; Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK.; Brewer D; Institute of Cancer Research, Sutton, London, UK.; University of East Anglia, Norwich, UK.; Eeles R; Institute of Cancer Research, Sutton, London, UK.; Cooper C; Institute of Cancer Research, Sutton, London, UK.; University of East Anglia, Norwich, UK.; Neal D; Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK.; Lynch AG; Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK.; Visakorpi T; Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland.; Isaacs WB; Johns Hopkins University, Baltimore, MD, USA.; Veer LV; Netherlands Cancer Institute, Amsterdam, Netherlands.; Caldas C; Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK.; Desmedt C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.; Aparicio S; British Columbia Cancer Agency, Vancouver, Canada.; Foekens JA; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.; Eyfjörd JE; Cancer Research Laboratory, University of Iceland, Reykjavik, Iceland.; Lakhani SR; School of Medicine, University of Queensland, Brisbane, Australia.; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia.; UQ Centre for Clinical Research, University of Queensland, Brisbane, Australia.; Thomas G; Université Lyon 1, Institut National du Cancer (INCa)-Synergie, Lyon, France.; Myklebost O; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Span PN; Department of Radiation Oncology and Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.; Børresen-Dale AL; Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Richardson AL; Dana-Farber Cancer Institute, Boston, MA, USA.; Van de Vijver M; Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands.; Vincent-Salomon A; Institut Bergonié, 229 cours de l'Argone, 33076 Bordeaux, France.; Institut Curie, Department of Tumor Biology, 26 rue d'Ulm, 75248 Paris cédex 05, France.; Van den Eynden GG; Translational Cancer Research Unit and Department of Pathology, GZA Hospitals, Antwerp, Belgium.; Flanagan AM; Royal National Orthopaedic Hospital, Middlesex, UK.; UCL Cancer Institute, University College London, London, UK.; Futreal PA; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; MD Anderson Cancer Center, Houston, TX, USA.; Janes SM; Lungs for Living Research Centre, Rayne Institute, University College London (UCL), London, UK.; Bova GS; Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland.; Stratton MR; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; McDermott U; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK.; Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Alexandrov LB; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Nik-Zainal S; Wedge DC; Aparicio SA; Behjati S; Biankin AV; Bignell GR; Bolli N; Borg A; Børresen-Dale AL; Boyault S; Burkhardt B; Butler AP; Caldas C; Davies HR; Desmedt C; Eils R; Eyfjörd JE; Foekens JA; Greaves M; Hosoda F; Hutter B; Ilicic T; Imbeaud S; Imielinski M; Jäger N; Jones DT; Jones D; Knappskog S; Kool M; Lakhani SR; López-Otín C; Martin S; Munshi NC; Nakamura H; Northcott PA; Pajic M; Papaemmanuil E; Paradiso A; Pearson JV; Puente XS; Raine K; Ramakrishna M; Richardson AL; Richter J; Rosenstiel P; Schlesner M; Schumacher TN; Span PN; Teague JW; Totoki Y; Tutt AN; Valdés-Mas R; van Buuren MM; van 't Veer L; Vincent-Salomon A; Waddell N; Yates LR; Zucman-Rossi J; Futreal PA; McDermott U; Lichter P; Meyerson M; Grimmond SM; Siebert R; Campo E; Shibata T; Pfister SM; Campbell PJ; Stratton MR

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Yates LR; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Campbell PJ

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100962779 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-0064 (Electronic) Linking ISSN: 14710056 NLM ISO Abbreviation: Nat Rev Genet Subsets: MEDLINE

Stephens PJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1SA, UK.; Tarpey PS; Davies H; Van Loo P; Greenman C; Wedge DC; Nik-Zainal S; Martin S; Varela I; Bignell GR; Yates LR; Papaemmanuil E; Beare D; Butler A; Cheverton A; Gamble J; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; Lau KW; McLaren S; McBride DJ; Menzies A; Mudie L; Raine K; Rad R; Chapman MS; Teague J; Easton D; Langerød A; Lee MT; Shen CY; Tee BT; Huimin BW; Broeks A; Vargas AC; Turashvili G; Martens J; Fatima A; Miron P; Chin SF; Thomas G; Boyault S; Mariani O; Lakhani SR; van de Vijver M; van 't Veer L; Foekens J; Desmedt C; Sotiriou C; Tutt A; Caldas C; Reis-Filho JS; Aparicio SA; Salomon AV; Børresen-Dale AL; Richardson AL; Campbell PJ; Futreal PA; Stratton MR

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Bowcock SJ; Minchom A; Yates LR; Ryali MM

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Mitchell TJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Academic Urology Group, Department of Surgery, Addenbrooke's Hospitals NHS Foundation Trust, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.; Turajlic S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Rowan A; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.; Nicol D; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Farmery JHR; CRUK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK.; O'Brien T; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Martincorena I; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Tarpey P; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Angelopoulos N; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Yates LR; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Butler AP; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Raine K; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Stewart GD; Academic Urology Group, Department of Surgery, Addenbrooke's Hospitals NHS Foundation Trust, University of Cambridge, Hills Road, Cambridge CB2 0QQ, UK.; Challacombe B; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Fernando A; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Lopez JI; Department of Pathology, Cruces University Hospital, Biocruces Institute, University of the Basque Country (UPV/EHU), Barakaldo, Spain.; Hazell S; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.; Chandra A; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Chowdhury S; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Rudman S; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Soultati A; Guy's and St Thomas' National Health Service (NHS) Foundation Trust, Great Maze Pond, London SE1 9RT, UK.; Stamp G; Experimental Histopathology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.; Fotiadis N; Interventional Radiology Department, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Pickering L; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Au L; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Spain L; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Lynch J; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Stares M; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Teague J; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Maura F; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Wedge DC; Big Data Institute, University of Oxford, Old Road Campus, Oxford OX3 7FZ, UK.; Horswell S; Bioinformatics and Biostatistics STP, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.; Chambers T; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.; Litchfield K; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.; Xu H; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK.; Stewart A; Bioinformatics and Biostatistics STP, Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.; Elaidi R; Hôpital Européen Georges Pompidou 20, rue Leblanc, 75908 Paris, France.; Oudard S; Hôpital Européen Georges Pompidou 20, rue Leblanc, 75908 Paris, France.; McGranahan N; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK.; Csabai I; Department of Physics of Complex Systems, Eotvos Lorand University, Budapest, Hungary.; Gore M; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Futreal PA; The University of Texas MD Anderson Cancer Center, Department of Genomic Medicine, Houston, TX 77030, USA.; Larkin J; Renal and Skin Units, The Royal Marsden National Health Service (NHS) Foundation Trust, London SW3 6JJ, UK.; Lynch AG; CRUK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK; School of Medicine, University of St. Andrews, North Haugh, St. Andrews KY16 9TF, UK.; Szallasi Z; Centre for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark; Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, MA, USA.; Swanton C; Translational Cancer Therapeutics Laboratory, the Francis Crick Institute, 1 Midland Rd, London NW1 1AT, UK; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London WC1E 6BT, UK; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London NW1 2BU, UK. Electronic address: charles.swanton@crick.ac.uk.; Campbell PJ; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Haematology, University of Cambridge, Cambridge CB2 2XY, UK. Electronic address: pc8@sanger.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 0413066 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4172 (Electronic) Linking ISSN: 00928674 NLM ISO Abbreviation: Cell Subsets: MEDLINE

Yates LR; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK.; Knappskog S; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Wedge D; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK.; Farmery JHR; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.; Gonzalez S; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK.; Martincorena I; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Alexandrov LB; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA.; Van Loo P; The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium.; Haugland HK; Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Lilleng PK; Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Gundem G; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA.; Gerstung M; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK.; Pappaemmanuil E; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA.; Gazinska P; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK.; Bhosle SG; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Jones D; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Raine K; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Mudie L; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Latimer C; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Sawyer E; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK.; Desmedt C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium.; Sotiriou C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium.; Stratton MR; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.; Sieuwerts AM; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands.; Lynch AG; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.; Martens JW; Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands.; Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Tutt A; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK.; Lønning PE; Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: per.eystein.lonning@helse-bergen.no.; Campbell PJ; Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: pc8@sanger.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Yates LR; The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: ly2@sanger.ac.uk.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Yates LR; Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom.; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London, United Kingdom.; Desmedt C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. christine.desmedt@bordet.be.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Davies H; Wellcome Trust Sanger Institute, Hinxton, UK.; Glodzik D; Wellcome Trust Sanger Institute, Hinxton, UK.; Morganella S; Wellcome Trust Sanger Institute, Hinxton, UK.; Yates LR; Wellcome Trust Sanger Institute, Hinxton, UK.; Guy's and St Thomas' NHS Trust, London, UK.; Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Zou X; Wellcome Trust Sanger Institute, Hinxton, UK.; Ramakrishna M; Wellcome Trust Sanger Institute, Hinxton, UK.; Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK.; Martin S; Wellcome Trust Sanger Institute, Hinxton, UK.; Boyault S; Translational Research Lab Department, Centre Léon Bérard, Lyon, France.; Sieuwerts AM; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Simpson PT; Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; King TA; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Raine K; Wellcome Trust Sanger Institute, Hinxton, UK.; Eyfjord JE; Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland.; Kong G; Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea.; Borg Å; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.; Birney E; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK.; Stunnenberg HG; Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands.; van de Vijver MJ; Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands.; Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway.; Martens JW; Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands.; Span PN; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Lakhani SR; Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia.; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.; Vincent-Salomon A; Department of Pathology, Institut Curie, Paris, France.; INSERM U934, Institut Curie, Paris, France.; Sotiriou C; Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium.; Tutt A; Breast Cancer Now Research Unit, King's College, London, UK.; Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK.; Thompson AM; Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Van Laere S; Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.; HistoGeneX, Wilrijk, Belgium.; Richardson AL; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Viari A; Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France.; Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France.; Campbell PJ; Wellcome Trust Sanger Institute, Hinxton, UK.; Stratton MR; Wellcome Trust Sanger Institute, Hinxton, UK.; Nik-Zainal S; Wellcome Trust Sanger Institute, Hinxton, UK.; East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE